Compared to our previous meta-analysis about the application of radiomics in prognosing lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) [45], the quality of the studies about immunotherapy was better, except in the study-confounding domain. This evidence concerns the gene EGFR and lung cancer.